by The EPA and DHA omega-3 fatty acids are found in fish oils and are essential nutrients for the human body. They provide various health benefits such as improved heart health, joint and brain function. The growing nutraceutical industry has increased the demand for EPA and DHA ingredients in dietary supplements.
The global EPA and DHA Market is estimated to be valued at US$ 2135.1 Mn in 2024 and is expected to exhibit a CAGR of 4.5% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The rising nutraceutical industry is one of the major drivers of the EPA and DHA market. Nutraceuticals containing EPA and DHA are being increasingly used to manage conditions such as cardiovascular diseases, depression, and cancers. Growing health awareness among consumers has spurred the demand for dietary supplements with polyunsaturated fatty acids (PUFAs) like EPA and DHA. The nutraceutical industry has observed strong growth over the past few years and this trend is expected to continue over the forecast period. This will correspondingly drive the market for EPA and DHA ingredients during this time.
SWOT Analysis
Strength: The EPA and DHA market has various health benefits associated with it such as maintaining heart health, improving brain function, eye health, etc. which is driving its increased demand.
Weakness: High costs associated with extraction and purification of EPA and DHA from marine sources make it inaccessible for low and middle-income consumers.
Opportunity: Rising health-consciousness among consumers and increasing adoption of nutraceuticals offer lucrative growth opportunities. Growing vegan population has led to increased demand for algal sources of EPA and DHA.
Threats: Volatility in prices of marine raw materials and inconsistencies associated with their quality/purity can hamper market growth. Stringent regulations are a challenge for industry players.
Key Takeaways
Global EPA And DHA Market Size is expected to witness high growth at a CAGR of 4.5% during the forecast period of 2024 to 2031 to reach a market size of US$ 2135.1 million by 2031.
North America currently dominates the market owing to high health awareness and large consumption of supplements. Europe is also a major region where countries like Norway, Denmark are major fish producers with high per capita fish consumption.
Key players operating in the EPA and DHA market are KHS GmbH, Tetra Pak International SA, Syntegon Technology GmbH, JBT Corporation, GEA Group Aktiengesellschaft, Sidel Group, Krones AG, Ronchi Mario SPA, Coesia Group, and Barry-Wehmiller Companies Inc. The industry is fragmented with the presence of global as well as regional players. Players are investing in R&D and focusing on new product launches to strengthen their market position.
New product innovation and launches targeting specific health concerns have boosted the demand. Algal or plant-based sources are gaining traction due to increasing vegan population and sustainable sourcing preferences. Companies are adopting strategies like capacity expansion, mergers and acquisitions for business growth.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
